bioRxiv Science⌕ Search

Biology subjects

Netti, P. A.

Publications and source records attributed to Netti, P. A..

2 recordsLinked to original sources

Standardizing mechanical dose delivery to cells via nanogroove-guided alignment

The development of novel mechanomedicine technologies critically depends on the ability to administer a well-defined mechanical dosage to cells. Unlike chemical cues, mechanical signals are vectorial rather than scalar, making their precise delivery inherently complex. When external mechanical stimuli are applied to cells seeded on a flat substrate, the mechanical dose experienced by each cell varies depending on its orientation and conformation, rendering consistent and effective mechano-modulation impractical. Here, we introduce a substrate-guided mechanical stimulation strategy that standardizes mechanical dose delivery at the population level by controlling cell orientation. Using nanogrooved PDMS substrates integrated into a uniaxial stretching platform, we induced coherent alignment of NIH3T3 fibroblasts and their mechanosensitive subcellular structures along the direction of applied strains. Cells cultured on flat or nanogrooved substrates were subjected to sustained uniaxial strains of 8% and 29%, and their responses were quantified in real time by live-cell fluorescence imaging. Nanogroove-induced alignment enabled uniform transmission of substrate strain to focal adhesions and the cytoskeleton, resulting in coherent and quantifiable nuclear deformation across the cell population. In contrast, cells on flat substrates exhibited orientation-dependent deformation modes that canceled out at the population level, leading to heterogeneous and attenuated responses. While cellular adaptation to sustained strain was primarily governed by strain magnitude, substrate-guided alignment markedly reduced cell-to-cell variability in mechanical signal perception. Overall, this work establishes cell alignment as a key parameter for standardizing mechanical dose delivery and improving the reproducibility of mechanobiology experiments and the design of mechanically active biomaterials.

bioengineering↗

Mechanobiology-guided drug repurposing identifies budesonide as an inhibitor of stiffness-induced PDAC aggressiveness

Pancreatic ductal adenocarcinoma (PDAC) develops within a desmoplastic and stiffened microenvironment that critically shapes tumor progression and therapeutic resistance, yet these features are not reproduced by conventional rigid plastic culture systems. Here, we leverage a tuneable bioengineered platform that mimics stromal stiffening to investigate how mechanical cues regulate PDAC cell behaviour and to identify pharmacological strategies that counteract stiffness-driven malignancy. We show that increasing matrix stiffness promotes key hallmarks of PDAC aggressiveness, including enhanced cell spreading, focal adhesions maturation, and cytoskeletal tension. Notably, we identify the glucocorticoid budesonide as a selective suppressor of stiffness-induced malignant phenotypes. Transcriptomic profiling reveals that budesonide counteracts stiffness-associated gene programs, prominently affecting pathways governing cytoskeletal dynamics, nuclear envelope organization, and YAP nucleocytoplasmic transport. Consistently, budesonide reduced force transmission to the nucleus, restoring nuclear wrinkling and constraining nuclear size and shape. These effects are mediated through both glucocorticoid receptor-dependent and -independent mechanisms, revealing a previously unrecognized mode of action. Together, our findings establish mechanical context as a critical determinant of PDAC vulnerability and identify budesonide as a candidate for therapeutic repurposing to target stiffness-driven cancer progression.

bioengineering↗